SFDA flags misleading medical device ad; violations could draw SR5 million fine
RIYADH — The Saudi Food and Drug Authority (SFDA) detected a non-compliant advertisement containing inaccurate and exaggerated claims about a medical device, a violation that could carry penalties of up to SR5 million. The advertisement promoted a medical device used to reduce pain and improve joint function in cases of mild osteoarthritis, but included claims that violated regulations governing…
In Riyadh, the Saudi Food and Drug Authority (SFDA) uncovered an advertisement for a medical device that contained inaccurate and exaggerated claims, potentially leading to penalties of up to SR5 million. The ad promoted a device aimed at reducing pain and enhancing joint function for mild osteoarthritis patients, but its language breached rules for advertising medical devices.
The SFDA promptly imposed legal action on the responsible company, while closing the medical facility involved. The company promoting the device faced further legal consequences following the referral to relevant authorities. The SFDA clarified that the violations contravene the Medical Devices and Supplies Law and its regulations.
Consequences include fines, temporary facility closure, restricted activities for up to 180 days, and potential license revocation. The authority encouraged citizens to report violations via the unified number 19999 and to rely on official sources for health-related information.
Written by urgent.news from Saudi Gazette's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
